TB vaccines in clinical development

TB vaccines in clinical development

Zobrazit další vydání (2)

The 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 - 24 April 2015, brought together a wide and diverse community involved in tuberculosis vaccine research and development to discuss the current status of, and future directions for this critical effort. This paper summarizes t...

Podrobná bibliografie
Hlavní autoři:	Ginsberg, A, Ruhwald, M, Mearns, H, Mcshane, H
Médium:	Journal article
Vydáno:	Elsevier 2016

Podobné jednotky

TB vaccines in clinical development
Autor: Ginsberg, AM, a další
Vydáno: (2016)

TB vaccines in clinical development
Autor: Ginsburg, A, a další
Vydáno: (2016)

TB vaccine development: where are we and why is it so difficult?
Autor: Wilkie, M, a další
Vydáno: (2014)

A review of clinical models for the evaluation of human TB vaccines.
Autor: O'Shea, M, a další
Vydáno: (2016)

Progress and challenges in TB vaccine development
Autor: Voss, G, a další
Vydáno: (2018)

Towards new TB vaccines
Autor: Brazier, B, a další
Vydáno: (2020)

Need for more TB vaccine field sites.
Autor: Mcshane, H
Vydáno: (2009)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
Autor: Mcshane, H
Vydáno: (2008)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
Autor: Minassian, A, a další
Vydáno: (2011)

New TB vaccine granted orphan drug status.
Autor: Lang, T, a další
Vydáno: (2005)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
Autor: Pepponi, I, a další
Vydáno: (2017)

Co-infection with HIV and TB: double trouble.
Autor: Mcshane, H
Vydáno: (2005)

Progress and challenges in TB vaccine development [version 1; referees: 2 approved]
Autor: Gerald Voss, a další
Vydáno: (2018-02-01)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data.
Autor: McShane, H, a další
Vydáno: (2014)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
Autor: McShane, H, a další
Vydáno: (2014)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
Autor: Thomas, Z, a další
Vydáno: (2014)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
Autor: Angela M Minassian, a další
Vydáno: (2011-01-01)

Identification and evaluation of novel protective antigens for the development of a candidate TB subunit vaccine
Autor: Stylianou, E, a další
Vydáno: (2018)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
Autor: Pathan, A, a další
Vydáno: (2012)

Phase I/II clinical trial of MVA85A in individuals with latent tuberculosis: The first subunit TB vaccine in clinical trial
Autor: Sander, C, a další
Vydáno: (2005)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
Autor: Odutola, A, a další
Vydáno: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
Autor: Odutola, A, a další
Vydáno: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
Autor: Pathan, A, a další
Vydáno: (2012)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents
Autor: Rustomjee, R, a další
Vydáno: (2013)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
Autor: Tameris, M, a další
Vydáno: (2014)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents.
Autor: Rustomjee, R, a další
Vydáno: (2013)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
Autor: Whelan, K, a další
Vydáno: (2009)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
Autor: Tameris, M, a další
Vydáno: (2014)

Clinical Development of New TB Vaccines: Recent Advances and Next Steps
Autor: Mark Hatherill, a další
Vydáno: (2020-01-01)

Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
Autor: Owiafe, P, a další
Vydáno: (2012)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
Autor: Pinpathomrat, N, a další
Vydáno: (2021)

Tuberculosis vaccines in clinical trials.
Autor: Rowland, R, a další
Vydáno: (2011)

Developing an improved vaccine against tuberculosis.
Autor: Mcshane, H
Vydáno: (2004)

Bayesian Augmented Clinical Trials in TB Therapeutic Vaccination
Autor: Dimitrios Kiagias, a další
Vydáno: (2021-10-01)

Experimental animal modelling for TB vaccine development
Autor: Pere-Joan Cardona, a další
Vydáno: (2017-03-01)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
Autor: Harris, S, a další
Vydáno: (2011)

Insights and challenges in tuberculosis vaccine development
Autor: McShane, H
Vydáno: (2019)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
Autor: Meyer, J, a další
Vydáno: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
Autor: Meyer, J, a další
Vydáno: (2013)

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults
Autor: Riste, M, a další
Vydáno: (2021)